InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Rubin Eyal, 首席财务官. Insider active across 1 company, notably Protalix BioTherapeutics, Inc.. Cumulatively, 4 reports have been logged. Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Rubin Eyal is Directeur Financier and Sr. VP and CFO at Protalix BioTherapeutics, Inc. He has 4 filings in total, and the sampled recent filings run from 2022-02-28 to 2024-11-05, with the transaction nature shown as Attribution.